[1]
|
Berger, J. and Hinglais, N. (1968) [Intercapillary Deposits of IgA-IgG]. Journal of Urology and Nephrology, 74, 694- 695.
|
[2]
|
Jarrick, S., et al. (2019) Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study. Jour-nal of the American Society of Nephrology, 30, 866-876. https://doi.org/10.1681/ASN.2018101017
|
[3]
|
Rajasekaran, A., Julian, B.A. and Rizk, D.V. (2021) IgA Nephrop-athy: An Interesting Autoimmune Kidney Disease. The American Journal of the Medical Sciences, 361, 176-194. https://doi.org/10.1016/j.amjms.2020.10.003
|
[4]
|
McGrogan, A., Franssen, C.F. and de Vries, C.S. (2011) The Incidence of Primary Glomerulonephritis Worldwide: A Systematic Review of the Literature. Nephrology Dialysis Transplantation, 26, 414-430.
https://doi.org/10.1093/ndt/gfq665
|
[5]
|
Woo, K.T., et al. (2010) Global Evolutionary Trend of the Prevalence of Primary Glomerulonephritis over the Past Three Decades. Nephron Clinical Practice, 116, c337-c346. https://doi.org/10.1159/000319594
|
[6]
|
Floege, J. and Amann, K. (2016) Primary Glomerulonephritides. The Lancet, 387, 2036-2048.
https://doi.org/10.1016/S0140-6736(16)00272-5
|
[7]
|
商华. IgA肾病免疫发病机制研究新进展[J]. 中国医药科学, 2021, 11(20): 60-63, 105.
|
[8]
|
邓振领, 王悦. IgA肾病患者肾小球系膜区沉积的IgA1来源的研究进展[J]. 生理科学进展, 2019, 50(2): 146-148.
|
[9]
|
Suzuki, H., et al. (2014) Cytokines Alter IgA1 O-Glycosylation by Dysregu-lating C1GalT1 and ST6GalNAc-II Enzymes. Journal of Biological Chemistry, 289, 5330-5339. https://doi.org/10.1074/jbc.M113.512277
|
[10]
|
Gharavi, A.G., et al. (2008) Aberrant IgA1 Glycosylation Is Inher-ited in Familial and Sporadic IgA Nephropathy. Journal of the American Society of Nephrology, 19, 1008-1014. https://doi.org/10.1681/ASN.2007091052
|
[11]
|
Xing, Y., et al. (2020) C1GALT1 Expression Is Associated with Galactosylation of IgA1 in Peripheral B Lymphocyte in Immunoglobulin a Nephropathy. BMC Nephrology, 21, Article No. 18. https://doi.org/10.1186/s12882-019-1675-5
|
[12]
|
Wang, Y., et al. (2021) Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy. Journal of the American Society of Nephrology, 32, 545-552.
https://doi.org/10.1681/ASN.2020060823
|
[13]
|
Takahata, A., et al. (2020) Crucial Role of AIM/CD5L in the De-velopment of Glomerular Inflammation in IgA Nephropathy. Journal of the American Society of Nephrology, 31, 2013-2024. https://doi.org/10.1681/ASN.2019100987
|
[14]
|
Suzuki, H., et al. (2011) The Pathophysiology of IgA Nephropathy. Journal of the American Society of Nephrology, 22, 1795-1803. https://doi.org/10.1681/ASN.2011050464
|
[15]
|
Brown, G.J., et al. (2022) TLR7 Gain-of-Function Genetic Varia-tion Causes Human Lupus. Nature, 605, 349-356.
https://doi.org/10.1038/s41586-022-04642-z
|
[16]
|
Zachova, K., et al. (2022) Galactose-Deficient IgA1 B Cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors. Journal of the American Society of Nephrology, 33, 908-917. https://doi.org/10.1681/ASN.2021081086
|
[17]
|
Takeda, K. and Akira, S. (2004) TLR Signaling Pathways. Semi-nars in Immunology, 16, 3-9.
https://doi.org/10.1016/j.smim.2003.10.003
|
[18]
|
Makita, Y., et al. (2020) TLR9 Activation Induces Aberrant IgA Glycosylation via APRIL- and IL-6-Mediated Pathways in IgA Nephropathy. Kidney International, 97, 340-349. https://doi.org/10.1016/j.kint.2019.08.022
|
[19]
|
Yu, X.Q., et al. (2011) A Genome-Wide Association Study in Han Chinese Identifies Multiple Susceptibility Loci for IgA Nephropathy. Nature Genetics, 44, 178-182. https://doi.org/10.1038/ng.1047
|
[20]
|
Schneider, P., et al. (1999) BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth. Journal of Experimental Medicine, 189, 1747-1756. https://doi.org/10.1084/jem.189.11.1747
|
[21]
|
McCarthy, D.D., et al. (2011) Mice Overexpressing BAFF Develop a Commensal Flora-Dependent, IgA-Associated Nephropathy. Journal of Clinical Investigation, 121, 3991-4002. https://doi.org/10.1172/JCI45563
|
[22]
|
Takahara, M., et al. (2019) A Proliferation-Inducing Ligand (APRIL) In-duced Hyper-Production of IgA from Tonsillar Mononuclear Cells in Patients with IgA Nephropathy. Cellular Immu-nology, 341, Article ID: 103925.
https://doi.org/10.1016/j.cellimm.2019.103925
|
[23]
|
Zhai, Y.L., et al. (2016) Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy. Medicine, 95, e3099. https://doi.org/10.1097/MD.0000000000003099
|
[24]
|
Schmitt, R., et al. (2014) The Combined Role of Galac-tose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangi-al Cells: Implications for IgA Nephropathy. The Journal of Immunology, 193, 317-326. https://doi.org/10.4049/jimmunol.1302249
|
[25]
|
Groza, Y., et al. (2022) IL-6 and Its Role in IgA Nephropathy De-velopment. Cytokine & Growth Factor Reviews, 66, 1-14. https://doi.org/10.1016/j.cytogfr.2022.04.001
|